Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium | HCID 5360545 | — |
| Reactant | 5-(4'-(Bromomethyl)(1,1'-biphenyl)-2-yl)-1-trityl-1H-tetraazole | HCID 10053461 | — |
| Reactant | Sodium Methoxide | HCID 10942334 | — |
| Reactant | HCID 178439771 | HCID 178439771 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 178439238 | HCID 178439238 | 9% |
Reaction Steps
4-Hydroxy-6-ethyl-5-propyl-2-(trifluoromethyl)pyrimidine (1.2 g, 5 mmole) was converted to the sodium salt with sodium methoxide (275 mg). The sodium salt was dissolved in DMF and mixed with 2.8 g (5 mmole) of 5-(4'-bromomethylbiphenyl-2-yl)-1-trityl-1H-tetrazole [U.S. Pat. No. 4,870,186], and the mixture heated at 50° C. for 18 hours. The solvent was evaporated to dryness and the residue was triturated with excess water to give a gum which was extracted into EtoAc. The organic layer was washed with H2O twice, dried over Na2SO4 and evaporated to a thick oil (4 g). One gram of this oil was treated with dry HCl saturated methanol for 3 hours then evaporated to dryness. The residue was triturated with hexane twice and decanted to afford a gum. The rest of the material was treated in the same way to provide a total of 2 g of crude product. Flash chromatography through silica gel and elution with CHCl3 contg. 4% MeOH gave 210 mg of the desired compound as a white solid. TLC, Silica gel (CHCl3 -MeOH-NH4OH,7:3:2%) Rf 0.55 MS (DCI) [M+H]+ 469
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05185340 |
|---|
| Source dataset | uspto-grants-1993_02 |
|---|
| ORD ID | ord-6edb14eaff954501bb6716dfbec9d4b1 |
|---|
| Source note | uspto-grants-1993_02 |
|---|